Allena Pharmaceuticals, Inc.

OTCPK:ALNA.Q Voorraadrapport

Marktkapitalisatie: US$109.9k

Allena Pharmaceuticals Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Should You Review Recent Insider Transactions At Allena Pharmaceuticals, Inc. (NASDAQ:ALNA)?

Dec 29
Should You Review Recent Insider Transactions At Allena Pharmaceuticals, Inc. (NASDAQ:ALNA)?

Recent updates

First two cohorts enrolled in Allena's phase 2a trial of gout & kidney disease treatment

Jul 19

Allena Pharma reschedules special meeting to approve reverse stock split, shares fall

Jul 05

Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days

Jan 08

Should You Review Recent Insider Transactions At Allena Pharmaceuticals, Inc. (NASDAQ:ALNA)?

Dec 29
Should You Review Recent Insider Transactions At Allena Pharmaceuticals, Inc. (NASDAQ:ALNA)?

Allena Pharmaceuticals announces $10M bought deal

Dec 01

Allena Pharma's ALLN-346 shows encouraging action in early-stage study

Nov 30

Allena Pharmaceuticals (ALNA) Investor Presentation - Slideshow

Nov 11

Allena Pharmaceuticals EPS misses by $0.01

Nov 09

CEO

Allena Pharmaceuticals heeft geen CEO, of we hebben geen gegevens over hen.